Uncoupling of ER-mitochondrial calcium communication by transforming growth factor-β

被引:38
作者
Pacher, Pal [2 ]
Sharma, Kumar [1 ,3 ]
Csordas, Gyoergy [2 ]
Zhu, Yanqing [3 ]
Hajnoczky, Gyoergy [2 ]
机构
[1] Univ Calif San Diego, VA San Diego Healthcare Syst, La Jolla, CA 92093 USA
[2] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Ctr Novel Therapies Kidney Dis, Dept Med, Philadelphia, PA 19107 USA
基金
美国国家卫生研究院;
关键词
IP3; receptor; mitochondria; vascular smooth muscle cells; angiotensin II;
D O I
10.1152/ajprenal.90343.2008
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Pacher P, Sharma K, Csordas G, Zhu Y, Hajnoczky G. Uncoupling of ER-mitochondrial calcium communication by transforming growth factor-beta. Am J Physiol Renal Physiol 295: F1303-F1312, 2008. First published July 23, 2008; doi:10.1152/ajprenal.90343.2008.-Transforming growth factor-beta (TGF-beta) has been implicated as a key factor in mediating many cellular processes germane to disease pathogenesis, including diabetic vascular complications. TGF-beta alters cytosolic [Ca2+] ([Ca2+](c)) signals, which in some cases may result from the downregulation of the IP3 receptor Ca2+ channels (IP3R). Ca2+ released by IP3Rs is effectively transferred from endoplasmic reticulum (ER) to the mitochondria to stimulate ATP production and to allow feedback control of the Ca2+ mobilization. To assess the effect of TGF-beta on the ER-mitochondrial Ca2+ transfer, we first studied the [Ca2+](c) and mitochondrial matrix Ca2+ ([Ca2+](m)) signals in single preglomerular afferent arteriolar smooth muscle cells (PGASMC). TGF-beta pretreatment (24 h) decreased both the [Ca2+](c) and [Ca2+](m) responses evoked by angiotensin II or endothelin. Strikingly, the [Ca2+](m) signal was more depressed than the [Ca2+](c) signal and was delayed. In permeabilized cells, TGF-beta pretreatment attenuated the rate but not the magnitude of the IP3-induced [Ca2+](c) rise, yet caused massive depression of the [Ca2+](m) responses. ER Ca2+ storage and mitochondrial uptake of added Ca2+ were not affected by TGF-beta. Also, TGF-beta had no effect on mitochondrial distribution and on the ER-mitochondrial contacts assessed by two-photon NAD(P) H imaging and electron microscopy. Downregulation of both IP3R1 and IP3R3 was found in TGF-beta-treated PGASMC. Thus, TGF-beta causes uncoupling of mitochondria from the ER Ca2+ release. The sole source of this would be suppression of the IP3R-mediated Ca2+ efflux, indicating that the ER-mitochondrial Ca2+ transfer depends on the maximal rate of Ca2+ release. The impaired ER-mitochondrial coupling may contribute to the vascular pathophysiology associated with TGF-beta production.
引用
收藏
页码:F1303 / F1312
页数:10
相关论文
共 50 条
  • [21] Transforming Growth Factor-β Signaling Pathway in Patients With Kawasaki Disease
    Shimizu, Chisato
    Jain, Sonia
    Davila, Sonia
    Hibberd, Martin L.
    Lin, Kevin O.
    Molkara, Delaram
    Frazer, Jeffrey R.
    Sun, Shelly
    Baker, Annette L.
    Newburger, Jane W.
    Rowley, Anne H.
    Shulman, Stanford T.
    Davila, Sonia
    Burgner, David
    Breunis, Willemijn B.
    Kuijpers, Taco W.
    Wright, Victoria J.
    Levin, Michael
    Eleftherohorinou, Hariklia
    Coin, Lachlan
    Popper, Stephen J.
    Relman, David A.
    Fury, Wen
    Lin, Calvin
    Mellis, Scott
    Tremoulet, Adriana H.
    Burns, Jane C.
    CIRCULATION-CARDIOVASCULAR GENETICS, 2011, 4 (01) : 16 - U99
  • [22] Fibrosis growth factor 23 is a promoting factor for cardiac fibrosis in the presence of transforming growth factor-β1
    Kuga, Kazuhiro
    Kusakari, Yoichiro
    Uesugi, Ken
    Semba, Kentaro
    Urashima, Takashi
    Akaike, Toru
    Minamisawa, Susumu
    PLOS ONE, 2020, 15 (04):
  • [23] Interactions of transforming growth factor-β and angiotensin II in renal fibrosis
    Border, WA
    Noble, NA
    HYPERTENSION, 1998, 31 (01) : 181 - 188
  • [24] Transforming growth factor-β2 is elevated in skeletal muscle disorders
    Murakami, N
    McLennan, IS
    Nonaka, I
    Koishi, K
    Baker, C
    Hammond-Tooke, G
    MUSCLE & NERVE, 1999, 22 (07) : 889 - 898
  • [25] CISD2 counteracts the inhibition of ER-mitochondrial calcium transfer by anti-apoptotic BCL-2
    Loncke, Jens
    de Ridder, Ian
    Kale, Justin
    Wagner, Larry
    Kaasik, Allen
    Parys, Jan B.
    Kerkhofs, Martijn
    Andrews, David W.
    Yule, David
    Vervliet, Tim
    Bultynck, Geert
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2025, 1872 (01):
  • [26] Transforming growth factor-β and multidrug resistance in chronic lymphocytic leukemia
    William R Friedenberg
    Sherry A Salzman
    Sonja M Phan
    James K Burmester
    Medical Oncology, 1999, 16 : 110 - 118
  • [27] Enhanced tumorigenesis and reduced transforming growth factor-β type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-β1
    Kang, Y
    Mariano, JM
    Angdisen, J
    Moody, TW
    Diwan, BA
    Wakefield, LM
    Jakowlew, SB
    MOLECULAR CARCINOGENESIS, 2000, 29 (02) : 112 - 126
  • [28] Hesperetin: An inhibitor of the transforming growth factor-β (TGF-β) signaling pathway
    Yang, Yong
    Wolfram, Joy
    Shen, Haifa
    Fang, Xiaohong
    Ferrari, Mauro
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 58 : 390 - 395
  • [29] Targeting Fibrosis for the Treatment of Heart Failure: A Role for Transforming Growth Factor-β
    Edgley, Amanda J.
    Krum, Henry
    Kelly, Darren J.
    CARDIOVASCULAR THERAPEUTICS, 2012, 30 (01) : e30 - e40
  • [30] A Selective Transforming Growth Factor-β Ligand Trap Attenuates Pulmonary Hypertension
    Yung, Lai-Ming
    Nikolic, Ivana
    Paskin-Flerlage, Samuel D.
    Pearsall, R. Scott
    Kumar, Ravindra
    Yu, Paul B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 194 (09) : 1140 - 1151